ALTIMMUNE, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ALTIMMUNE, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2018-09-30 was $535.26K.
- ALTIMMUNE, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2018-06-30 was $4.04M.
- ALTIMMUNE, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2018-03-31 was $5.22M.
- ALTIMMUNE, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2010-12-31 was $4.80M.
- ALTIMMUNE, INC. stock issued during period, value, conversion of convertible securities for fiscal 2016 was $6.00M.
- ALTIMMUNE, INC. stock issued during period, value, conversion of convertible securities for fiscal 2010 was $21.83M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2018-09-30 | $535.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | |
| 2018-06-30 | $4.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | |
| 2018-03-31 | $5.22M 10-Q · filed 2018-05-15 | |
| 2016-12-31 | $6.00M 10-K · filed 2018-04-02 | |
| 2010-12-31 | $4.80M 10-K · filed 2014-03-11 | $21.83M 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |